HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: A case-control study

Infectious Agents and Cancer

Volumn 6, Issue 1, 2011, Pages

  Odida, Michael ^a,b   Sandin, Sven ^a   Mirembe, Florence ^b   Kleter, Bernhard ^c   Quint, Wim ^c   Weiderpass, Elisabete ^a,d,e,f  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MAKERERE UNIVERSITY   (Uganda)

^c DDL DIAGNOSTIC LABORATORY   (Netherlands)

^d CANCER REGISTRY OF NORWAY   (Norway)

^e UNIVERSITY OF TROMSØ   (Norway)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIV TEST; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; INVASIVE CERVICAL CARCINOMA; PRIORITY JOURNAL; SEROLOGY; SQUAMOUS CELL CARCINOMA; UGANDA; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 79959418123     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-6-8     Document Type: Article

References (54)

1. Cervical carcinoma in Southern Mexico: Human papillomavirus and cofactors. B Illades-Aguiar EM Cortes-Malagon V Antonio-Vejar N Zamudio-Lopez LC Alarcon-Romero G Fernandez-Tilapa D Hernandez-Sotelo MA Teran-Porcayo E Flores-Alfaro MA Leyva-Vazquez, Cancer Detect Prev 2009 32 300 307 10.1016/j.cdp.2008.09.001 19022588
2. Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. G Busnach P Piselli E Arbustini U Baccarani P Burra MP Carrieri F Citterio E De Juli S Bellelli C Pradier G Rezza D Serraino Immunosuppression and Cancer Study Group, Transplant Proc 2006 38 3533 3535 10.1016/j.transproceed.2006.10.144 17175324 (Pubitemid 44908520)
3. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. FX Bosch MM Manos N Munoz M Sherman AM Jansen J Peto MH Schiffman V Moreno R Kurman KV Shah, J Natl Cancer Inst 1995 87 796 802 10.1093/jnci/87.11. 796 7791229
4. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. X Castellsague M Diaz S de Sanjosé N Mũoz R Herrero S Franceschi RW Peeling R Ashley JS Smith PJ Snijders CJ Meijer FX Bosch International Agency for Research on Cancer Multicenter Cervical Cancer Study Group, J Natl Cancer Inst 2006 98 303 315 10.1093/jnci/djj067 16507827 (Pubitemid 43338210)
5. Linkage of AIDS and cancer registries in Italy. S Franceschi L Dal Maso S Arniani RA Lo A Barchielli C Milandri L Simonato M Vercelli R Zanetti G Rezza, Int J Cancer 1998 75 831 834 10.1002/(SICI)1097-0215(19980316)75:6<831::AID- IJC33.0.CO;2-W 9506526 (Pubitemid 28134106)
6. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. M Frisch RJ Biggar JJ Goedert, J Natl Cancer Inst 2000 92 1500 1510 10.1093/jnci/92.18.1500 10995805
7. Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. R Schmauz P Okong EM de Villiers R Dennin L Brade SK Lwanga R Owor, Int J Cancer 1989 43 805 809 10.1002/ijc.2910430511 2714885 (Pubitemid 19138185)
8. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa. J ter Meulen HC Eberhardt J Luande HN Mgaya J Chang-Claude H Mtiro M Mhina P Kashaija S Ockert X Yu G Meinhardt L Gissmannl M Pawlita, Int J Cancer 1992 51 515 521 10.1002/ijc.2910510403 1318265
9. Epidemiology of AIDS-related tumours in developed and developing countries. L Dal Maso D Serraino S Franceschi, Eur J Cancer 2001 37 1188 1201 10.1016/S0959-8049(01)00120-4 11423251 (Pubitemid 32553764)
10. Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. S Franceschi L Dal Maso P Pezzotti J Polesel C Braga P Piselli D Serraino G Tagliabue M Federico S Ferretti V De Lisi F La Rosa E Conti M Budroni G Vicario S Piffer F Pannelli A Giacomin F Bell R Tumino M Fusco G Rezza Cancer and AIDS Registry Linkage Study, J Acquir Immune Defic Syndr 2003 34 84 90 10.1097/00126334-200309010-00013 14501799 (Pubitemid 37100117)
11. HIV infection among Uganda women with cervical cancer: a retrospective study. WK Sekirime R Gray, Gynecol Obstet Invest 2007 63 222 228 10.1159/000098197 17191009 (Pubitemid 46742310)
12. Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. C Kahesa J Mwaiselage HR Wabinga T Ngoma JN Kalyango CA Karamagi, BMC Public Health 2008 8 262 10.1186/1471-2458-8-262 18664298
13. Changing cancer incidence in Kampala, Uganda, 1991-2006. DM Parkin S Nambooze F Wabwire-Mangen HR Wabinga, Int J Cancer 2010 126 1187 1195 19688826
14. HIV prevalence in voluntary counseling and testing centers compared with national HIV serosurvey data in Uganda. F Baryarama RE Bunnell L Montana W Hladik A Opio J Musinguzi W Kirungi L Waswa-Bright JH Mermin, J Acquir Immune Defic Syndr 2008 49 183 189 10.1097/QAI.0b013e31818455b8 18769350
15. Optimizing the delivery of HIV counseling and testing services: the Uganda experience using rapid HIV antibody test algorithms. RG Downing RA Otten E Marum B Biryahwaho MG Alwano-Edyegu SD Sempala CA Fridlund TJ Dondero C Campbell MA Rayfield, J Acquir Immune Defic Syndr Hum Retrovirol 1998 18 384 388 10.1097/00042560-199808010-00011 9704945
16. Bias reduction of maximum likelihood estimates. D Firth, Biometrika 1993 80 27 38 10.1093/biomet/80.1.27
17. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. GM Clifford JS Smith T Aguado S Franceschi, Br J Cancer 2003 89 101 105 10.1038/sj.bjc.6601024 12838308 (Pubitemid 36897943)
18. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. JS Smith L Lindsay B Hoots J Keys S Franceschi R Winer GM Clifford, Int J Cancer 2007 121 621 632 10.1002/ijc.22527 17405118 (Pubitemid 46986496)
19. Human papillomavirus types among women infected with HIV: a meta-analysis. GM Clifford MA Goncalves S Franceschi, AIDS 2006 20 2337 2344 10.1097/01.aids.0000253361.63578.14 17117020 (Pubitemid 44789536)
20. The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group Study. CA Chen CY Liu HH Chou CY Chou CM Ho NF Twu YY Kan MH Chuang TY Chu CY Hsieh, Int J Gynecol Cancer 2006 16 1801 1808 10.1111/j.1525-1438.2006.00655.x 17009975
21. The viral origin of cervical cancer in Rabat, Morocco. N Chaouki FX Bosch N Mũoz CJ Meijer B El Gueddari A El Ghazi J Deacon X Castellsague JM Walboomers, Int J Cancer 1998 75 546 554 10.1002/(SICI)1097-0215(19980209)75: 4<546::AID-IJC93.0.CO;2-T 9466654 (Pubitemid 28094099)
22. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study. A Ferrera JP Velema M Figueroa R Bulnes LA Toro JM Claros O De Barahona WJ Melchers, Int J Cancer 1999 82 799 803 10.1002/(SICI)1097-0215(19990909)82:6<799::AID-IJC53.0.CO;2-5 10446444 (Pubitemid 29384328)
23. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. DB Thomas Q Qin J Kuypers N Kiviat RL Ashley A Koetsawang RM Ray S Koetsawang, Am J Epidemiol 2001 153 732 739 10.1093/aje/153.8.732 11296144 (Pubitemid 32319699)
24. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. S Franceschi T Rajkumar S Vaccarella V Gajalakshmi A Sharmila PJ Snijders N Mũoz CJ Meijer R Herrero, Int J Cancer 2003 107 127 133 10.1002/ijc.11350 12925967 (Pubitemid 37100096)
25. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. AP Sowjanya M Jain UR Poli S Padma M Das KV Shah BN Rao RR Devi PE Gravitt G Ramakrishna, BMC Infect Dis 2005 5 116 10.1186/1471-2334-5- 116 16371167
26. Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. S Bulk J Berkhof NW Bulkmans GD Zielinski L Rozendaal FJ van Kemenade PJ Snijders CJ Meijer, Br J Cancer 2006 94 171 175 10.1038/sj.bjc. 6602915 16404371 (Pubitemid 43088560)
27. Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models. LL Reimers WF Anderson PS Rosenberg DE Henson PE Castle, Cancer Epidemiol Biomarkers Prev 2009 18 792 800 10.1158/1055-9965.EPI-08-0965 19258470
28. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. JS Smith C Bosetti N Mũoz R Herrero FX Bosch J Eluf-Neto CJ Meijer AJ Van Den Brule S Franceschi RW Peeling, Int J Cancer 2004 111 431 439 10.1002/ijc.20257 15221973 (Pubitemid 38998826)
29. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. MM Madeleine T Anttila SM Schwartz P Saikku M Leinonen JJ Carter M Wurscher LG Johnson DA Galloway JR Daling, Int J Cancer 2007 120 650 655 10.1002/ijc.22325 17096345 (Pubitemid 44969037)
30. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. AS Kapeu T Luostarinen E Jellum J Dillner M Hakama P Koskela P Lenner A Love E Mahlamaki S Thoresen L Tryggvadáttir G Wadell L Youngman M Lehtinen, Am J Epidemiol 2009 169 480 488 19074773
31. Uganda Demographic and Health Survay 2000-2001. Uganda Bureau of Statistics (UBOS), ORC Macro, Cleverton, Maryland, USA, UBOS and ORC Macro 2001
32. Tobacco use among high shool students in Kampala, Uganda: questionnaire study. L Mpabulungi AS Muula, Croat Med J 2004 45 80 83 14968459 (Pubitemid 38404922)
33. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. JL Pretet AC Jacquard X Carcopino JF Charlot D Bouhour B Kantelip B Soubeyrand Y Leocmach C Mougin D Riethmuller, Int J Cancer 2008 122 428 432 10.1002/ijc.23092 17893882 (Pubitemid 350234732)
34. Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype. P de Cremoux A de la Rochefordière A Savignoni Y Kirova S Alran V Fourchotte C Plancher M Thioux RJ Salmon P Cottu L Mignot X Sastre-Garau, Int J Cancer 2009 124 778 782 10.1002/ijc.24075 19035459
35. HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: an analysis of HPV genotypes. DIANAIDS Collaborative Study Group. G Cappiello AR Garbuglia R Salvi G Rezza M Giuliani P Pezzotti B Suligoi M Branca G Migliore D Formigoni-Pomponi C D'Ubaldo G Ippolito G Giacomini A Benedetto, Int J Cancer 1997 72 982 986 10.1002/(SICI)1097- 0215(19970917)72:6<982::AID-IJC113.0.CO;2-7 9378562 (Pubitemid 27433562)
36. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. SE Hawes CW Critchlow PS Sow P Toure I N'Doye A Diop JM Kuypers AA Kasse NB Kiviat, J Natl Cancer Inst 2006 98 100 109 10.1093/jnci/djj010 16418512 (Pubitemid 43159964)
37. Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program. LS Massad EC Seaberg DH Watts NA Hessol S Melnick P Bitterman K Anastos S Silver AM Levine H Minkoff, AIDS 2004 18 109 113 10.1097/00002030-200401020-00013 15090836 (Pubitemid 38402324)
38. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. JR Moodley M Hoffman H Carrara BR Allan DD Cooper L Rosenberg LE Denny S Shapiro AL Williamson, BMC Cancer 2006 6 135 10.1186/1471-2407-6-135 16719902
39. Risk of cancer in persons with AIDS in Italy, 1985-1998. L Dal Maso S Franceschi J Polesel C Braga P Piselli E Crocetti F Falcini S Guzzinati R Zanetti M Vercelli G Rezza Cancer and AIDS Registy Linkage Study, Br J Cancer 2003 89 94 100 10.1038/sj.bjc.6601017 12838307 (Pubitemid 36897942)
40. Cancer risk in people infected with human immunodeficiency virus in the United States. EA Engels RJ Biggar HI Hall H Cross A Crutchfield JL Finch R Grigg T Hylton KS Pawlish TS McNeel JJ Goedert, Int J Cancer 2008 123 187 194 10.1002/ijc.23487 18435450 (Pubitemid 351705208)
41. Risk of human papillomavirus-associated cancers among persons with AIDS. AK Chaturvedi MM Madeleine RJ Biggar EA Engels, J Natl Cancer Inst 2009 101 1120 1130 10.1093/jnci/djp205 19648510
42. Human papillomavirus infection and disease in HIV-infected individuals. ME Hagensee JE Cameron JE Leigh RA Clark, Am J Med Sci 2004 328 57 63 10.1097/00000441-200407000-00008 15254442 (Pubitemid 38943958)
43. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. P Schuman SE Ohmit RS Klein A Duerr S Cu-Uvin DJ Jamieson J Anderson KV Shah, J Infect Dis 2003 188 128 136 10.1086/375783 12825181 (Pubitemid 36829752)
44. Langerhans' cell count and HLA class II profile in cervical intraepithelial neoplasia in the presence or absence of HIV infection. MA Goncalves EG Soares AP Fernandes BA Fonseca JS Bettini RT Simoes EA Donadi, Eur J Obstet Gynecol Reprod Biol 2004 114 221 227 10.1016/j.ejogrb.2003.10.026 15140519 (Pubitemid 38622086)
45. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. MN Didelot-Rousseau N Nagot V Costes-Martineau X Valles A Ouedraogo I Konate HA Weiss P Van de Perre P Mayaud M Segondy, Br J Cancer 2006 95 355 362 10.1038/sj.bjc.6603252 16832413 (Pubitemid 44187597)
46. Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. JE Koshiol JC Schroeder DJ Jamieson SW Marshall A Duerr CM Heilig KV Shah RS Klein S Cu-Uvin P Schuman D Celentano JS Smith, Int J Cancer 2006 119 1623 1629 10.1002/ijc.22015 16646070 (Pubitemid 44258768)
47. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. AE Luque M Jabeen S Messing CA Lane LM Demeter RC Rose RC Reichman, J Infect Dis 2006 194 428 434 10.1086/505876 16845625 (Pubitemid 44162653)
48. Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya. H De Vuyst P Gichangi B Estambale E Njuguna S Franceschi M Temmerman, Int J Cancer 2008 122 244 246 10.1002/ijc.23045 17764116 (Pubitemid 350210001)
49. Biology of HPV in HIV infection. J Palefsky, Adv Dent Res 2006 19 99 105 10.1177/154407370601900120 16672559
50. Slow progression of HIV-1 infection in a cohort of antiretroviral naive hotel workers in Dar es Salaam, Tanzania as defined by their CD4 cell slopes. M Bakari W Urassa F Mhalu G Biberfeld K Pallangyo E Sandstrom, Scand J Infect Dis 2008 40 407 413 10.1080/00365540701708285 17943637 (Pubitemid 351566568)
51. Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naive Ugandans. J Serwanga LA Shafer E Pimego B Auma C Watera S Rowland D Yirrell P Pala H Grosskurth J Whitworth F Gotch P Kaleebu, PLoS One 2009 4 4188 10.1371/journal.pone.0004188 19142234
52. Elite control of HIV infection: implications for vaccine design. BM Baker BL Block AC Rothchild BD Walker, Expert Opin Biol Ther 2009 9 55 69 10.1517/14712590802571928 19063693
53. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection. WB Dyer JJ Zaunders FF Yuan B Wang JC Learmont AF Geczy NK Saksena DA McPhee PR Gorry JS Sullivan, Retrovirology 2008 5 112 10.1186/1742-4690-5-112 19077215
54. Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting. S Mangclaviraj SJ Kerr S Chaithongwongwatthana J Ananworanich B Hirschel S Emery DA Cooper P Chotnopparatpattara K Ruxrungtham P Phanuphak, Int J STD AIDS 2008 19 529 532 10.1258/ijsa.2007.007222 18663038